Greenwich Lifesciences, Inc. (($GLSI)) announced an update on their ongoing clinical study. Greenwich LifeSciences, Inc. is conducting a Phase 3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback